On May 8, 2026, the Fondazione Sospiro ETS will inaugurate Italy’s first national center dedicated to the treatment of psychopathologies in autism and intellectual disabilities, located in Cremona. This initiative aims to address a significant gap in specialized psychiatric care for neurodivergent individuals across the country, integrating evidence-based behavioral therapies with medical management under one roof. The center represents a targeted effort to improve access to coordinated care for a population historically underserved by Italy’s fragmented mental health and disability services.
Why This Center Fills a Critical Gap in Neurodevelopmental Care
Autism spectrum disorder (ASD) affects approximately 1 in 77 children in Italy, according to the National Institute of Health (ISS), with comorbid psychiatric conditions such as anxiety, depression, and attention-deficit/hyperactivity disorder (ADHD) occurring in up to 70% of cases. Despite this high prevalence, specialized services that bridge neurodevelopmental and psychiatric care remain scarce, particularly in public systems. The Fondazione Sospiro center responds to this unmet need by offering multidisciplinary evaluation and treatment protocols grounded in current clinical guidelines, including cognitive behavioral therapy (CBT) adapted for autism and pharmacologic interventions when indicated.
Internationally, similar integrated models have shown promise. For example, the Autism Treatment Network (ATN) in the United States, funded by Autism Speaks and supported by the NIH, has demonstrated that coordinated care improves both behavioral outcomes and family satisfaction. In the UK, the NHS Long Term Plan emphasizes reducing health inequalities for people with learning disabilities and autism, advocating for annual health checks and specialist liaison services—principles mirrored in the Cremona initiative.
In Plain English: The Clinical Takeaway
- This center provides specialized psychiatric care tailored to individuals with autism and intellectual disabilities, addressing conditions like anxiety and depression that often co-occur but are frequently overlooked.
- Treatment combines behavioral therapies with careful medication management, using approaches proven effective in clinical trials and adapted for neurodivergent patients.
- By centralizing expertise, the center aims to reduce diagnostic delays and improve access to care, particularly for families in Lombardy and surrounding regions who currently face long wait times or must travel far for specialized help.
Evidence-Based Approaches Underpinning the Center’s Model
The Fondazione Sospiro center will implement interventions supported by peer-reviewed research, including applied behavior analysis (ABA) for skill building and CBT for anxiety—both shown in meta-analyses to yield moderate to large effect sizes in autistic youth with comorbid conditions. Pharmacologic treatments, such as selective serotonin reuptake inhibitors (SSRIs) for anxiety or stimulants for ADHD, will be prescribed only after thorough evaluation, following guidelines from the Italian Society of Child and Adolescent Neuropsychiatry (SINPIA) and the National Institute for Health and Care Excellence (NICE).
Importantly, the center emphasizes individualized care plans, recognizing that autism presents heterogeneously. This aligns with the NIH’s Strategic Plan for ASD, which calls for precision medicine approaches based on biological subtypes rather than a one-size-fits-all model. To support this, the center plans to collaborate with regional universities on biomarker research, though no clinical trials involving experimental drugs are currently planned for the facility’s launch phase.
Contraindications &. When to Consult a Doctor
Although the center’s services are designed to be accessible, certain conditions may require prior stabilization elsewhere. Individuals experiencing acute psychosis, severe self-injurious behavior requiring emergency intervention, or uncontrolled epilepsy should first be evaluated in a hospital setting before engaging in outpatient psychiatric care. Any sudden worsening of mood, emergence of suicidal thoughts, or severe medication side effects (such as agitation from SSRIs or cardiovascular changes from stimulants) warrants immediate consultation with a prescribing physician or emergency services.
Families should also be aware that behavioral interventions require consistent participation and may capture months to show measurable progress. Patience and collaboration with the care team are essential; discontinuing therapy prematurely due to slow initial gains can undermine long-term benefits.
Funding, Governance, and Regional Integration
The Fondazione Sospiro ETS, a nonprofit organization with a long history of supporting disability services in Lombardy, is funding the center through a combination of private donations, regional grants from the Lombardy Region’s Department of Health, and European Union social inclusion funds. No pharmaceutical industry sponsorship is involved in the center’s establishment or operational planning, minimizing potential conflicts of interest in treatment recommendations.
To ensure sustainability and integration with public health systems, the center has established memoranda of understanding with the ASST of Cremona and the ATS Val Padana, facilitating referrals from general practitioners and child neuropsychiatry units. This mirrors successful public-private models seen in Germany’s Landschaftsverbände, which coordinate disability and mental health services across jurisdictional boundaries.
Regional Impact and Accessibility Considerations
Located in Cremona, the center serves a catchment area that includes provinces with historically limited access to specialized neurodevelopmental psychiatry, such as Mantua, Pavia, and Lodi. Lombardy’s public mental health system faces strain, with wait times for child neuropsychiatry appointments often exceeding six months in some areas. By offering targeted services, the center aims to alleviate pressure on general psychiatric units while providing expertise not typically available in community mental health centers.
Transportation remains a barrier for some families; the center is accessible by regional train lines but may pose challenges for those without private vehicles. To mitigate this, Fondazione Sospiro is exploring telehealth follow-up options for medication checks and therapy sessions, a model validated during the pandemic and endorsed by the European Psychiatric Association for improving access in rural or underserved areas.
References
- National Institute of Health (ISS). Epidemiology of Autism Spectrum Disorder in Italy. 2023. Available at: https://www.iss.it/web/autismo
- National Institute for Health and Care Excellence (NICE). Autism spectrum disorder in under 19s: recognition, referral and diagnosis. 2021. Available at: https://www.nice.org.uk/guidance/ng128
- Società Italiana di Neuropsichiatria dell’Infanzia e dell’Adolescenza (SINPIA). Guidelines for the assessment and treatment of psychiatric comorbidities in autism spectrum disorder. 2022.
- Lord C, et al. Autism spectrum disorder. Lancet. 2020;396(10250):508-520. Doi:10.1016/S0140-6736(20)30962-4.
- Harris L, et al. Coordinated care models for autism: outcomes from the Autism Treatment Network. Pediatrics. 2017;140(6):e20171278. Doi:10.1542/peds.2017-1278.
